Latest Insider Transactions at Organogenesis Holdings Inc. (ORGO)
This section provides a real-time view of insider transactions for Organogenesis Holdings Inc. (ORGO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Organogenesis Holdings Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Organogenesis Holdings Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2023
|
Michele Ilene Korfin Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,737
+42.31%
|
-
|
|
Feb 22
2023
|
Gilberto Quintero Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,737
+42.31%
|
-
|
|
Feb 22
2023
|
Prathyusha Duraibabu Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,737
+40.24%
|
-
|
|
Feb 22
2023
|
Gary S. Gillheeney President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
896,414
+33.56%
|
-
|
|
Feb 22
2023
|
David Francisco Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
242,508
+45.38%
|
-
|
|
Feb 22
2023
|
Patrick Bilbo Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
327,386
+39.33%
|
-
|
|
Feb 22
2023
|
Brian Grow Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
291,009
+43.72%
|
-
|
|
Feb 22
2023
|
Lori Freedman Chief Admin. and Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
278,884
+44.61%
|
-
|
|
Feb 22
2023
|
Antonio S. Montecalvo Vice President, Health Policy |
BUY
Grant, award, or other acquisition
|
Direct |
99,428
+41.7%
|
-
|
|
Feb 22
2023
|
Arthur S Leibowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,737
+32.49%
|
-
|
|
Feb 22
2023
|
Jon L Giacomin Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,737
+41.78%
|
-
|
|
Feb 22
2023
|
Michael Joseph Driscoll Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,737
+41.87%
|
-
|
|
Feb 16
2023
|
Brian Grow Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
799
-0.95%
|
$1,598
$2.75 P/Share
|
|
Feb 16
2023
|
Lori Freedman Chief Admin. and Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
765
-1.12%
|
$1,530
$2.75 P/Share
|
|
Feb 16
2023
|
Antonio S. Montecalvo Vice President, Health Policy |
SELL
Payment of exercise price or tax liability
|
Direct |
717
-1.78%
|
$1,434
$2.75 P/Share
|
|
Feb 16
2023
|
Gary S. Gillheeney President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,787
-0.43%
|
$7,574
$2.75 P/Share
|
|
Feb 16
2023
|
David Francisco Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
953
-1.89%
|
$1,906
$2.75 P/Share
|
|
Feb 16
2023
|
Patrick Bilbo Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
936
-0.52%
|
$1,872
$2.75 P/Share
|
|
Feb 15
2023
|
Brian Grow Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,346
-3.81%
|
$6,692
$2.92 P/Share
|
|
Feb 15
2023
|
Lori Freedman Chief Admin. and Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,635
-5.06%
|
$7,270
$2.92 P/Share
|
|
Feb 15
2023
|
Antonio S. Montecalvo Vice President, Health Policy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,249
-3.01%
|
$2,498
$2.92 P/Share
|
|
Feb 15
2023
|
Gary S. Gillheeney President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,517
-2.38%
|
$43,034
$2.92 P/Share
|
|
Feb 15
2023
|
David Francisco Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,506
-6.51%
|
$7,012
$2.92 P/Share
|
|
Feb 15
2023
|
Patrick Bilbo Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,599
-2.51%
|
$9,198
$2.92 P/Share
|
|
Nov 21
2022
|
Michael W Katz > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
3,000
+3.78%
|
$6,000
$2.56 P/Share
|
|
Nov 18
2022
|
Michael W Katz > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
3,000
+3.93%
|
$6,000
$2.57 P/Share
|
|
Aug 20
2022
|
Brian Grow Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
805
+0.91%
|
$805
$1.46 P/Share
|
|
Aug 12
2022
|
Arthur S Leibowitz Director |
BUY
Open market or private purchase
|
Direct |
3,000
+4.06%
|
$12,000
$4.75 P/Share
|
|
Aug 12
2022
|
Michael Joseph Driscoll Director |
BUY
Open market or private purchase
|
Direct |
5,000
+16.37%
|
$20,000
$4.8 P/Share
|
|
Jun 30
2022
|
Gary S. Gillheeney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
505,050
+35.86%
|
$0
$0.99 P/Share
|
|
Jun 13
2022
|
Albert Erani > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
59,338
-0.05%
|
$237,352
$4.89 P/Share
|
|
Jun 09
2022
|
Albert Erani > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
662
-0.0%
|
$3,310
$5.3 P/Share
|
|
Jun 08
2022
|
Albert Erani > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
40,000
-0.03%
|
$200,000
$5.39 P/Share
|
|
Jun 07
2022
|
Albert Erani > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-0.08%
|
$500,000
$5.49 P/Share
|
|
Jun 06
2022
|
Albert Erani > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
200,000
-0.17%
|
$1,000,000
$5.41 P/Share
|
|
Jun 03
2022
|
Gary S. Gillheeney President and CEO |
SELL
Open market or private sale
|
Direct |
36,239
-8.34%
|
$181,195
$5.53 P/Share
|
|
Jun 03
2022
|
Gary S. Gillheeney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,239
+7.7%
|
$0
$0.99 P/Share
|
|
Jun 02
2022
|
Gary S. Gillheeney President and CEO |
SELL
Open market or private sale
|
Direct |
116,608
-22.65%
|
$583,040
$5.58 P/Share
|
|
Jun 02
2022
|
Gary S. Gillheeney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
116,608
+18.47%
|
$0
$0.99 P/Share
|
|
Jun 01
2022
|
Gary S. Gillheeney President and CEO |
SELL
Open market or private sale
|
Direct |
94,487
-19.18%
|
$472,435
$5.52 P/Share
|
|
Jun 01
2022
|
Gary S. Gillheeney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
94,487
+16.09%
|
$0
$0.99 P/Share
|
|
May 31
2022
|
Gary S. Gillheeney President and CEO |
SELL
Open market or private sale
|
Direct |
109,240
-21.53%
|
$546,200
$5.68 P/Share
|
|
May 31
2022
|
Gary S. Gillheeney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
109,240
+17.71%
|
$0
$0.99 P/Share
|
|
May 27
2022
|
Gary S. Gillheeney President and CEO |
SELL
Open market or private sale
|
Direct |
56,362
-12.4%
|
$281,810
$5.93 P/Share
|
|
May 27
2022
|
Gary S. Gillheeney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
56,362
+11.03%
|
$0
$0.99 P/Share
|
|
May 26
2022
|
Gary S. Gillheeney President and CEO |
SELL
Open market or private sale
|
Direct |
61,202
-13.32%
|
$306,010
$5.71 P/Share
|
|
May 26
2022
|
Gary S. Gillheeney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
61,202
+11.76%
|
$0
$0.99 P/Share
|
|
May 25
2022
|
Gary S. Gillheeney President and CEO |
SELL
Open market or private sale
|
Direct |
84,674
-17.53%
|
$423,370
$5.6 P/Share
|
|
May 25
2022
|
Gary S. Gillheeney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
84,674
+14.92%
|
$0
$0.99 P/Share
|
|
May 24
2022
|
Gary S. Gillheeney President and CEO |
SELL
Open market or private sale
|
Direct |
52,312
-11.61%
|
$261,560
$5.66 P/Share
|